FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Batycky Richard P.

2. Date of Event Requiring Statement (MM/DD/YYYY)
6/9/2015 

3. Issuer Name and Ticker or Trading Symbol

ACORDA THERAPEUTICS INC [ACOR]

(Last)        (First)        (Middle)

420 SAW MILL RIVER ROAD

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
Chief Tech. Off. & Site Head /

(Street)

ARDSLEY, NY 10502       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4) 		2. Amount of Securities Beneficially Owned
(Instr. 4) 		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) 		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   47979   (1) D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4) 		2. Date Exercisable and Expiration Date
(MM/DD/YYYY) 		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) 		4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) 		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy)     (2) 10/22/2024   Common Stock   26750   $32.27   D    
Employee Stock Option (right to buy)     (2) 10/29/2024   Common Stock   73250   $35.88   D    
Employee Stock Option (right to buy)     (3) 3/4/2025   Common Stock   5546   $35.74   D    

Explanation of Responses:
( 1)  Restricted stock issued under the Company's 2006 Employee Incentive Plan. 25,000 of these shares will vest 25% every year for four years with vest dates of October 22, 2015, October 22, 2016, October 22, 2017, and October 22, 2018. 22,000 of these shares will vest over three years, with 20% vesting on November 7, 2015, 30% vesting on November 7, 2016, and the remaining 50% vesting on November 7, 2017. 979 of these shares will vest 25% every year for four years with vest dates of December 1, 2015, December 1, 2016, December 1, 2017, and December 1, 2018.
( 2)  Twenty-five percent of the shares subject to this option will vest on October 22, 2015. The balance of the shares subject to this option will vest in equal quarterly installments over the three years thereafter.
( 3)  The shares subject to this option vest in equal quarterly installments over four years beginning on January 1, 2015 with the first quarterly installment vesting on April 1, 2015.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Batycky Richard P.
420 SAW MILL RIVER ROAD
ARDSLEY, NY 10502

Chief Tech. Off. & Site Head

Signatures
/s/ Richard P. Batycky 7/2/2015
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Acorda Therapeutics (NASDAQ:ACOR)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Acorda Therapeutics Charts.
Acorda Therapeutics (NASDAQ:ACOR)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Acorda Therapeutics Charts.